Kesatuan Eropah - Romania - EMA (European Medicines Agency)

sanofi winthrop industrie - sarilumab - artrita, reumatoida - imunosupresoare - kevzara în asociere cu metotrexat (mtx) este indicat pentru tratamentul moderat la sever activă artrita reumatoida (ra) la pacienţii adulţi care au răspuns inadecvat la, sau care sunt intoleranta la unul sau mai multe boli modificarea anti-reumatice droguri (dmard). kevzara poate fi administrat ca monoterapie în caz de intoleranţă la mtx sau atunci când tratamentul cu mtx este inadecvat.

Moldova - Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

zentiva k.s. - leflunomidum - comprimate - 10 mg

Moldova - Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

zentiva k.s. - leflunomidum - comprimate filmate - 20 mg

Kesatuan Eropah - Romania - EMA (European Medicines Agency)

sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agenți pentru dermatită, cu excepția corticosteroizilor - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.

Kesatuan Eropah - Romania - EMA (European Medicines Agency)

sanofi winthrop industrie - insulina lispro - diabetul zaharat - medicamente utilizate în diabet - pentru tratamentul adulților și copiilor cu diabet zaharat care necesită insulină pentru menținerea homeostaziei normale a glucozei. insulina lispro sanofi este de asemenea indicată pentru stabilizarea inițială a diabetului zaharat.

Romania - Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sanofi winthrop industrie - franta - amiodaronum - compr. - 200mg - antiaritmice clasa i si iii antiaritmice clasa iii

Romania - Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sanofi winthrop industrie - franta - acid valproicum + saruri - compr. gastrorez. - 200mg - antiepileptice derivati de acizi grasi

Romania - Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sanofi winthrop industrie - franta - acid valproicum + saruri - compr. cu elib. prel. - 300mg - antiepileptice derivati de acizi grasi

Romania - Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sanofi winthrop industrie - franta - acid valproicum + saruri - compr. cu elib. prel. - 500mg - antiepileptice derivati de acizi grasi

Kesatuan Eropah - Romania - EMA (European Medicines Agency)

sanofi winthrop industrie - insulina aspart - diabetul zaharat - medicamente utilizate în diabet - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.